Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Post by Gulliver1909on Jan 14, 2022 4:51pm
260 Views
Post# 34318944

Interim CFO and operational status

Interim CFO and operational statusTimely reaction. I think they found a very good interim CFO within a short period of time (3 weeks).

Buys them time to find a very good new CFO.

I am really curious abouth the first quarter and current operational status.

Fourth quarter of 2021 was impressive with a 1 million $ net profit. IF they can repeat that in the current year would lead to  4 million $ net profit per your or a price sales ratio of less than 10 (in regard of the cash position).

Quite a steal.

However I do not know if COVID did again put pressure on the operating results again - media talking aobut overcrowed hospitals again in the US due to the Omicron variant.
<< Previous
Bullboard Posts
Next >>